WiseCLIN is a Risk-Based Quality Management software for clinical trials that connects Critical-to-Quality factors, risks, controls, actions, metrics and review decisions in one place, helping sponsors and CROs manage and demonstrate effective and compliant RBQM.
Built to meet global requirements
When your risk information lives everywhere, oversight lives nowhere.
Critical-to-Quality factors are often documented during study planning but rarely linked to the risks, controls and metrics used during conduct. As a result, teams lose sight of what matters most to participant safety, data integrity and reliable study outcomes.
Risk assessments are frequently maintained in standalone Excel files that are difficult to control, update and share. This creates versioning issues, limits collaboration and makes it harder to ensure that risk information reflects the current state of the study.
Key Risk Indicators and Quality Tolerance Limits may sit across dashboards, reports and vendor platforms. Without a direct link to the underlying study risks, teams can see that a threshold has been crossed but struggle to understand its context, impact or required response.
Mitigation and control actions are often assigned and followed up through email chains. This makes it difficult to confirm ownership, due dates, implementation status and effectiveness, increasing the risk that important actions are delayed, overlooked or never formally closed.
Critical-to-Quality factors are often documented during study planning but rarely linked to the risks, controls and metrics used during conduct. As a result, teams lose sight of what matters most to participant safety, data integrity and reliable study outcomes.
Risk assessments are frequently maintained in standalone Excel files that are difficult to control, update and share. This creates versioning issues, limits collaboration and makes it harder to ensure that risk information reflects the current state of the study.
Key Risk Indicators and Quality Tolerance Limits may sit across dashboards, reports and vendor platforms. Without a direct link to the underlying study risks, teams can see that a threshold has been crossed but struggle to understand its context, impact or required response.
Mitigation and control actions are often assigned and followed up through email chains. This makes it difficult to confirm ownership, due dates, implementation status and effectiveness, increasing the risk that important actions are delayed, overlooked or never formally closed.
Risk-related decisions may be recorded in lengthy meeting minutes without being connected to the relevant risk or action. Finding the rationale behind a decision becomes time-consuming, particularly during audits, inspections or team transitions.
Sponsors, CROs and functional teams may each maintain their own trackers, reports and risk records. When information is not centralised, teams can act on outdated or inconsistent data, creating gaps in communication, escalation and oversight.
Risk scores may change over time, but the reason behind the change is not always clearly documented. Without a complete history of assessments, evidence and decisions, it becomes difficult to explain whether a risk has improved, deteriorated or simply been reassessed differently.
Oversight activities may occur across meetings, emails, dashboards and reports, but the supporting evidence remains fragmented. Sponsors can struggle to show how risks were reviewed, challenged, escalated and followed through during the full study lifecycle.
Some risks are reviewed routinely, while others are only revisited after an issue occurs. Without defined review cycles, triggers and responsibilities, risk assessments can quickly become outdated and fail to reflect emerging study conditions.
Risk-related decisions may be recorded in lengthy meeting minutes without being connected to the relevant risk or action. Finding the rationale behind a decision becomes time-consuming, particularly during audits, inspections or team transitions.
Sponsors, CROs and functional teams may each maintain their own trackers, reports and risk records. When information is not centralised, teams can act on outdated or inconsistent data, creating gaps in communication, escalation and oversight.
Risk scores may change over time, but the reason behind the change is not always clearly documented. Without a complete history of assessments, evidence and decisions, it becomes difficult to explain whether a risk has improved, deteriorated or simply been reassessed differently.
Oversight activities may occur across meetings, emails, dashboards and reports, but the supporting evidence remains fragmented. Sponsors can struggle to show how risks were reviewed, challenged, escalated and followed through during the full study lifecycle.
Some risks are reviewed routinely, while others are only revisited after an issue occurs. Without defined review cycles, triggers and responsibilities, risk assessments can quickly become outdated and fail to reflect emerging study conditions.
Valuable knowledge from completed studies is often stored in archived files or retained only by individual team members. When risks, controls and outcomes are not captured in a reusable format, each new study starts from scratch and the same problems may be repeated.
Critical-to-Quality factors are often documented during study planning but rarely linked to the risks, controls and metrics used during conduct. As a result, teams lose sight of what matters most to participant safety, data integrity and reliable study outcomes.
Risk assessments are frequently maintained in standalone Excel files that are difficult to control, update and share. This creates versioning issues, limits collaboration and makes it harder to ensure that risk information reflects the current state of the study.
Key Risk Indicators and Quality Tolerance Limits may sit across dashboards, reports and vendor platforms. Without a direct link to the underlying study risks, teams can see that a threshold has been crossed but struggle to understand its context, impact or required response.
Valuable knowledge from completed studies is often stored in archived files or retained only by individual team members. When risks, controls and outcomes are not captured in a reusable format, each new study starts from scratch and the same problems may be repeated.
Critical-to-Quality factors are often documented during study planning but rarely linked to the risks, controls and metrics used during conduct. As a result, teams lose sight of what matters most to participant safety, data integrity and reliable study outcomes.
Risk assessments are frequently maintained in standalone Excel files that are difficult to control, update and share. This creates versioning issues, limits collaboration and makes it harder to ensure that risk information reflects the current state of the study.
Key Risk Indicators and Quality Tolerance Limits may sit across dashboards, reports and vendor platforms. Without a direct link to the underlying study risks, teams can see that a threshold has been crossed but struggle to understand its context, impact or required response.
WiseCLIN's Risk-Based Oversight System, from risk scoring to inspection-ready compliance.
Focus your study team on what matters most by defining the CTQ factors that drive patient safety, data quality and trial success.
Identify study risks early, connect them to CTQ factors and build a clear, structured foundation for proactive risk management.
Prioritise risks using consistent likelihood, impact and detectability criteria, so teams know where to act first.
Convert risk insights into clear controls, actions, owners and timelines to reduce exposure and strengthen study oversight.
Keep risk management current with scheduled and trigger-based reviews that support timely decisions throughout the study.
Focus your study team on what matters most by defining the CTQ factors that drive patient safety, data quality and trial success.
Identify study risks early, connect them to CTQ factors and build a clear, structured foundation for proactive risk management.
Prioritise risks using consistent likelihood, impact and detectability criteria, so teams know where to act first.
Convert risk insights into clear controls, actions, owners and timelines to reduce exposure and strengthen study oversight.
Keep risk management current with scheduled and trigger-based reviews that support timely decisions throughout the study.
From global sponsors to single-site research teams — WiseCLIN fits the way you run trials.
Book a Demo
Smarter, risk-based oversight built to keep your clinical trials compliant, efficient, and in control.
Identify and address emerging risks earlier
Reduce manual effort and duplicated work
Strengthen ICH E6(R3) alignment and inspection readiness
Gain clearer oversight across studies, teams and portfolios
